Orange County is about to see the first initial public offering of 2025. Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...
Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering. In a recent SEC filing, the company said it was now looking to offer 10M ...
As per the analyst, the insulin pumps are a double-digit growth category, with the company taking share from the low base. The firm believes that Beta Bionics, Inc. (NASDAQ:BBNX)’s revenue in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results